Orthorexia Nervosa in Fibromyalgia
ConditionFibromyalgia
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-65
SponsorBeylikduzu State Hospital
About this trial
This clinical cross-sectional study will include 84 female patients aged between 18 and 65 years who have been diagnosed with fibromyalgia syndrome according to the 2010 American College of Rheumatology diagnostic criteria. Sociodemographic data will be recorded at the beginning of the study. Pain severity will be assessed using the Visual Analog Scale (VAS). Orthorexia nervosa-related symptoms will be evaluated with the ORTO-11 scale. Body image will be assessed with the Body Appreciation Scale 2, mood will be evaluated using the Hospital Anxiety and Depression Scale (HADS), and fibromyalgia-related impact will be assessed with the Fibromyalgia Impact Questionnaire (FIQ).
Eligibility criteria
Qualifiers
Female patients aged 18-65 years.
Diagnosis of fibromyalgia syndrome according to the 2010 American College of Rheumatology diagnostic criteria.
Willingness to participate and provision of written informed consent.
Disqualifiers
Refusal to participate.
Presence of diagnosed psychiatric disorders.
Presence of cognitive impairment.
Use of medications that may affect mood.
Trial design
Treatments tested in this trial
- Fibromyalgia
Treatment groups
84 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov